 SAN DIEGO, Jan. 4, 2021 PRNewswire -- Mirati Therapeutics, Inc. NASDAQ: MRTX, a clinical stage targeted oncology company, will present at the 39th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 11th at 12:40 p.m. PST 3:40 p.m. EST. Charles M. Baum, M.D.,... 